Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Femke De Snoo"'
Publikováno v:
Biomarker Insights, Vol 2010, Iss 5, Pp 129-138 (2010)
Externí odkaz:
https://doaj.org/article/9855d09981124152ae48fb76f60208a1
Publikováno v:
Biomarker Insights, Vol 5 (2010)
Background MammaPrint was developed as a diagnostic tool to predict risk of breast cancer metastasis using the expression of 70 genes. To better understand the tumor biology assessed by MammaPrint, we interpreted the biological functions of the 70-ge
Externí odkaz:
https://doaj.org/article/671e77d902324d9f81b7d69d665600a2
Autor:
Massimo Cristofanilli, Namita Chittoria, Sima Ehsani, Hallgeir Rui, Milana Dolezal, Lisette Stork-Sloots, Femke de Snoo, Christopher Recknor, Vandana Abramson
Publikováno v:
Cancer Research. 82:P5-17
Background C-C Chemokine Ligand type-5 (CCR5) is overexpressed in >95% of TNBC and has been correlated with disease progression. Moreover, enhancement of DNA repair signaling by CCR5 activation may contribute to chemotherapy resistance. Therefore, bl
Autor:
Noa Biran, Binod Dhakal, Suzanne Lentzsch, David Siegel, Saad Z. Usmani, Adriana Rossi, Cara Rosenbaum, Divaya Bhutani, David H. Vesole, Cesar Rodriguez, Ajay K. Nooka, Frits van Rhee, Lisette Stork-Sloots, Femke de Snoo, Pritish K. Bhattacharyya, DP Dash, Sena Zümrütçü, Martin van Vliet, Parameswaran Hari, Ruben Niesvizky
Publikováno v:
SSRN Electronic Journal.
Autor:
Jan Bogaerts, Laura J. van't Veer, Giuseppe Viale, Leen Slaets, Femke De Snoo, Leila Russo, Emiel J. Th. Rutgers, Martine Piccart-Gebhart, Lisette Stork-Sloots, Patrizia Dell'Orto, Fatima Cardoso, Annuska M. Glas
Publikováno v:
Breast Cancer Research and Treatment
Breast cancer research and treatment, 155 (3
Breast cancer research and treatment, 155 (3
Accurate identification of breast cancer patients most likely to benefit from adjuvant systemic therapies is crucial. Better understanding of differences between methods can lead to an improved ER, PgR, and HER-2 assessment. The purpose of this prepl
Autor:
Pino Cusumano, Jean Marc Guinebretière, Patrizia Querzoli, Gerhard Seitz, Bichlien Nguyen, Kenneth B. Deck, Lisette Stork-Sloots, Tiziana Perin, Femke De Snoo, Toru Watanabe, Carmela Giardina, Laura Dekker, Martijn Lutke-Holzik, Corrado Tinterri, Jelle Wesseling, Anna Sapino, Julie Barone, Paul Roepman, Fabrizio Zanconati
Publikováno v:
Virchows Archiv : an international journal of pathology. 469(3)
To compare results from messenger RNA (mRNA)-based TargetPrint testing with those from immunohistochemistry (IHC) and in situ hybridization (ISH) conducted according to local standard procedures at hospitals worldwide. Tumor samples were prospectivel
Autor:
Annuska M. Glas, Mireille Snel, Neil Barth, Els M.J.J. Berns, Lee B. Riley, Charles E. Cox, Luca Molinaro, Bichlien Nguyen, Sabine C. Linn, Leonie J. M. J. Delahaye, Paul Roepman, Jeroen van den Akker, Jelle Wesseling, Anna Sapino, David W. Anderson, Iris Simon, Femke De Snoo, Laura J. van't Veer
Publikováno v:
Journal of Molecular Diagnostics, 16(2), 190-197. Elsevier Inc.
MammaPrint, a prognostic 70-gene profile for early-stage breast cancer, has been available for fresh tissue. Improvements in RNA processing have enabled microarray diagnostics for formalin-fixed, paraffin-embedded (FFPE) tissue. Here, we describe met
Publikováno v:
Breast cancer research and treatment. 139(3)
The aim of this study was to analyze the correlation between the pathologic complete response (pCR) rate after neoadjuvant chemotherapy and long-term outcome (distant metastases-free survival [DMFS]) in patients with early-stage breast cancer using B
Autor:
Agustin A. Garcia, Femke De Snoo, Bichlien Nguyen, Lisette Stork-Sloots, Kenneth B. Deck, Daniele Generali, Pino Cusumano, Jeroen van den Akker, Katharine Yao, Edgardo Rivera, Deborah Kerlin, Julie Barone
Purpose. To compare breast cancer subtyping with the three centrally assessed microarray-based assays BluePrint, MammaPrint, and TargetPrint with locally assessed clinical subtyping using immunohistochemistry (IHC) and fluorescence in situ hybridizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a319ca90cd68e85d452ba138d10f4a69
https://hdl.handle.net/11368/2904241
https://hdl.handle.net/11368/2904241
Autor:
Wilbert Zwart, Annuska M. Glas, René Bernards, Oscar Krijgsman, Jason S. Carroll, Femke De Snoo, Sun Tian, R. Bender, Paul Roepman
Publikováno v:
Krijgsman, O, Roepman, P, Zwart, W, Carroll, J S, Tian, S, De Snoo, F A, Bender, R A, Bernards, R & Glas, A M 2012, ' A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response ', Breast Cancer Research and Treatment, vol. 133, no. 1, pp. 37-47 . https://doi.org/10.1007/s10549-011-1683-z
Breast Cancer Research and Treatment, 133(1), 37-47. Springer New York
Breast Cancer Research and Treatment, 133(1), 37-47. Springer New York
Classification of breast cancer into molecular subtypes maybe important for the proper selection of therapy, as tumors with seemingly similar histopathological features can have strikingly different clinical outcomes. Herein, we report the developmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e66a7bdb40cbf0dac500e735cd044fc
https://research.vumc.nl/en/publications/048dd9e2-86a0-4ab2-b3e2-dcd4713c9d50
https://research.vumc.nl/en/publications/048dd9e2-86a0-4ab2-b3e2-dcd4713c9d50